1. Department of Internal Medicine 1, Faculty of Medicine, Shimane University, Izumo, Japan
2. Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
3. Medicine Division, Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan
4. Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
5. Global Patient Safety & Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim, Germany
6. Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan
7. Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan
8. Division of Molecular and Metabolic Medicine, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, Kobe, Japan
9. Center for Healthcare Information Technology (C-HIT), Tokai National Higher Education and Research System, Nagoya, Japan
10. Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, China